SenesTech, Inc.

SNES

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
SNES
CIK0001680378
SIC2870
SectorManufacturing
Industry CategoryChemicals
Industry GroupAgriculture Chemicals

Contact

Address777 W. PINNACLE PEAK ROAD, SUITE B104, PHOENIX, AZ, 85027
Website senestech.com
Phone(928) 779 - 4143
CEOJoel Fruendt
Employees30

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$1.93 million
Pre-Tax Income$-6.02 million
Net Income$-6.02 million
Net Income to Common$-6.02 million
EPS$-4.63
View All
Balance Sheet
Cash$1.66 million
Assets$3.63 million
Liabilities$734,000.00
Common Equity$2.89 million
Liabilities & Equity$3.63 million
View All
Cash Flow Statement
Calculations
NOPAT$-4.25 million
EBITDA$-5.91 million
Price to EarningsN/A
Price to Book$1.73
ROE-160.41%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

SenesTech to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in fertility control solutions for managing rodent populations, today announced that it will participate in a webcast fireside chat and host one-on-one meetings with investors at the Lytham Partners Spring 2025 Investor Conference, taking place virtually on Thursday, May 29, 2025.

Article Link

SenesTech Inc (SNES) Q1 2025 Earnings Call Highlights: Evolve Product Line Drives Revenue Surge ...

SenesTech Inc (SNES) reports a 40% revenue growth in its Evolve product line, while facing hurdles in brick-and-mortar retail expansion.

Article Link

SenesTech Reports First Quarter 2025 Financial Results 40% Revenue Growth in Evolve™, Record Gross Profit Margins of 65%, and Continued Progress Toward Profitability

SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the first quarter ended March 31, 2024.

Article Link

SenesTech Announces Exclusive Distribution Agreement and Initial Order for Evolve™ Soft Bait in Indonesia

SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces its entry into an exclusive distribution agreement with Asa Jaya Mandiri LTD (AJM) for the commercialization of Evolve™ in Indonesia.

Article Link

SenesTech's Evolve™ Deployed in Chicago Neighborhoods

SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions for managing rodent populations, today confirmed the expanding deployment of EvolveTM Rat Birth Control in the Wicker Park Bucktown Special Service Area of Chicago.

Article Link